Eleanor joined Oxford AHSN in September 2021 to lead on reporting and programme management. Eleanor is an MBA qualified, experienced PMO and Programme Manager, who has specialised in financial analysis and management reporting in both public and private sectors for the last 12 years.
Oxford AHSN Directors and Board members are listed first. Scroll down or click through to the next pages for other members of the Oxford AHSN team. Alternatively, you can refine your search by using the specialties listed below.
Amelia works for both the Oxford and Kent Surrey Sussex AHSNs, joining in April 2022. She has a broad financial service background, with a key focus on environmental responsibility and sustainable practice. Amelia will focus on how the AHSNs’ support the NHS in achieving its net zero carbon ambition, embedding environmental sustainability in all initiatives […]
Hayley joined the Oxford AHSN in 2021. She is a mental health nurse and had experience working in acute inpatient care and treatment-resistant depression before becoming a safety and quality improvement lead across mental health and community health services. Hayley is a graduate of the Oxford AHSN Masters programme in partnership with the University of […]
Jon leads the deterioration programme. He joined the Oxford AHSN in 2021. Jon is an intensive care nurse by background. He has extensive experience in the Royal Air Force Medical Services where he held a variety of clinical leadership, assurance and policy development roles. Jon has a professional interest in human factors and ergonomics.
Nigel joined the Oxford AHSN in 2021. He has 25 years’ experience in the public sector, working in health and wellbeing roles, designing and implementing service improvements. He has an MBA qualification and has held a number of senior roles working alongside and within the NHS on wellbeing and deprivation projects. Throughout his career Nigel […]
*Currently on maternity leave* Lauren joined Oxford AHSN in January 2020 as a project manager. She has worked in both R&D and commercial roles within the medical device and pharmaceutical industry. She supports the AHSN market access team with early evidence generation for innovators.